BLLN
BillionToOne, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$99.39
−0.11%Forward multiples
Based on analyst estimates
- P/E forward
- 131.17x
- P/E 2026E
- 125.06x
- P/E 2027E
- 95.30x
- P/E 2028E
- 56.05x
- P/S forward
- 9.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- 144.02x
- PEG TTM
- 14.64x
- Price / book
- 8.74x
- Price / sales
- 11.80x
- Price / cash flow
- 103.41x
Enterprise value
- Enterprise value
- $4.3B
- EV / sales
- 10.78x
- EV / EBITDA
- 85.29x
- EV / EBIT
- 98.96x
- Market cap
- $4.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026